Kansenshogaku zasshi, Год журнала: 2024, Номер 98(6), С. 521 - 528
Опубликована: Окт. 18, 2024
Язык: Английский
Kansenshogaku zasshi, Год журнала: 2024, Номер 98(6), С. 521 - 528
Опубликована: Окт. 18, 2024
Язык: Английский
BMJ Open Respiratory Research, Год журнала: 2025, Номер 12(1), С. e002528 - e002528
Опубликована: Янв. 1, 2025
Background An estimated 10–30% of people with COVID-19 experience debilitating long-term symptoms or long covid. Underlying health conditions associated chronic inflammation may increase the risk Methods We conducted a systematic review and meta-analysis to examine whether covid was altered by pre-existing asthma obstructive pulmonary disease (COPD) in adults. identified studies searching PubMed Embase databases from inception 13 September 2024. excluded that focused on children defined only terms respiratory symptoms. used random-effects, restricted maximum likelihood models analyse data pooled 51 studies, which included 43 analyses 30 COPD. The bias assessed using ROBINS-E table. Results found 41% increased odds (95% CI 1.29 1.54); COPD 32% 1.16 1.51). Pre-existing asthma, but not COPD, covid-associated fatigue. observed heterogeneity results related hospitalisation status. Potential confounding inconsistent measurement exposure outcome variables were among limitations. Conclusions Our findings support hypothesis covid, including fatigue outcomes patients asthma. Because targets tract, these inflammatory lower tract could provide mechanistic clues common pathway for development sequelae
Язык: Английский
Процитировано
1Journal of Asthma, Год журнала: 2024, Номер 61(7), С. 736 - 744
Опубликована: Янв. 8, 2024
The purpose of this study was to assess: (1) the prevalence long COVID by asthma status, and (2) characteristics associated with developing among adults in United States.
Язык: Английский
Процитировано
4Journal of Evaluation in Clinical Practice, Год журнала: 2025, Номер 31(1)
Опубликована: Фев. 1, 2025
The positive effects of vaccination status on the course Long COVID symptoms have not been fully elucidated. Our aim is to determine most common in patients monitored COVID-19 follow-up clinic and examine whether there a difference between recovery rates those who are vaccinated vaccinated. Between December 1, 2020 April 30, 2022, prospectively collected data 916 were admitted outpatient tertiary hospital for first time evaluated as retrospective cohort this study. frequencies ten last examinations 478 with determined, their was compared. Patients divided into two groups according status. values showing obtained these compared themselves again. average age study group 54.43 ± 11.71 years, 255 (53.3%) male. median period 10 months. 84.7% had received at least one dose vaccine. Statistically significant results found improvement all never-vaccinated group. There no statistically CoronaVac, BNT162b2, heterologous (CoronaVac+ BNT162b2) vaccine groups. Factors affecting three (dyspnea, fatigue, forgetfulness) examined univariate logistic regression analysis, only or non-vaccination be risk factor. This showed that receiving may effective improving symptoms. Although differences inactive mRNA terms reducing symptoms, higher detected BNT162b2.
Язык: Английский
Процитировано
0Public Health, Год журнала: 2025, Номер 241, С. 47 - 54
Опубликована: Фев. 12, 2025
Язык: Английский
Процитировано
0Respiratory Investigation, Год журнала: 2025, Номер 63(3), С. 303 - 310
Опубликована: Март 5, 2025
Язык: Английский
Процитировано
0Journal of Brown Hospital Medicine, Год журнала: 2025, Номер unknown
Опубликована: Апрель 1, 2025
The coronavirus disease (COVID-19) pandemic was a global health crisis with far-reaching consequences. Among these were physical and mental complications that emerged weeks or even months after the initial COVID-19 infection, collectively termed “long COVID” “post-COVID syndrome.” Identifying epidemiology, risk factors, clinical manifestations, management strategies for long COVID is crucial both clinicians patients, which focus of this review. prevalence varies across studies, generally ranging from 5% to 20%. Prominent factors include female sex, older age, high number acute symptoms, lower socioeconomic status, underlying comorbidities such as diabetes, asthma, chronic obstructive pulmonary disease. manifestations are diverse; beyond commonly reported symptoms fatigue, malaise, ageusia, anosmia, neuropsychiatric headache, cognitive deficits, depression also potential outcomes. Although there currently no consensus on COVID, multidisciplinary care teams appropriate referrals follow-up diagnostic studies essential in evaluating course patients.
Язык: Английский
Процитировано
0Depression and Anxiety, Год журнала: 2025, Номер 2025(1)
Опубликована: Янв. 1, 2025
Background: Long‐COVID has attracted increased attention with rising numbers of affected patients and high individual symptom burden. Prior studies have described its prevalence, course disease, severity. Yet, the influence intensive care, including telemedical support for at risk a severe initial COVID‐19 on occurrence associated symptoms is studied to lesser extent. Methods: Here, we report long‐term results COVID‐SMART study, which randomized at‐risk either smartwatch‐based monitoring or standard care. We investigate symptoms, depression anxiety after 12 months. Findings: Between October 2020 May 2022, enrolled 607 in study. Complete 12‐month follow‐up was available 573 patients, 288 intervention group 285 control group. Overall, 234 participants (40.8%) reported COVID‐related prevalence (209 participants, 36.5%) (232 40.5%). However, did not reduce these follow‐up. Multivariable regression analysis identified sex, active smoking, pre‐existing asthma as significant predictors both outcomes. Interpretation: first prospective, clinical trial systematically assess impact care development anxiety. identify part modifiable factors does appear be beneficial reducing should hence focused acute infection phase. Trial Registration: ClinicalTrials.gov identifier: NCT04471636
Язык: Английский
Процитировано
0BMC Infectious Diseases, Год журнала: 2024, Номер 24(1)
Опубликована: Сен. 19, 2024
Язык: Английский
Процитировано
2Reproductive Biology and Endocrinology, Год журнала: 2024, Номер 22(1)
Опубликована: Июнь 7, 2024
Abstract Fatigue, an increasingly acknowledged symptom in various chronic diseases, has garnered heightened attention, during the medical era of bio-psycho-social model. Its persistence not only significantly compromises individual’s quality life but also correlates with organ damage. Surprisingly, intricate relationship between fatigue and female reproductive health, specifically infertility, remains largely unexplored. Our exploration into existing body evidence establishes a compelling link uterine ovarian as well conditions associated such rheumatism. This observation suggests potentially pivotal role influencing overall fertility. Furthermore, we propose hypothetical mechanism elucidating impact on infertility from multiple perspectives, postulating that neuroendocrine, neurotransmitter, inflammatory immune, mitochondrial dysfunction resulting its co-factors may further contribute to endocrine disorders, menstrual irregularities, sexual dysfunction, ultimately leading infertility. In addition providing this comprehensive theoretical framework, summarize anti-fatigue strategies accentuate current knowledge gaps. By doing so, our aim is offer novel insights, stimulate research, advance understanding crucial interplay health.
Язык: Английский
Процитировано
2Annals of Allergy Asthma & Immunology, Год журнала: 2024, Номер 133(5), С. 491 - 492
Опубликована: Авг. 9, 2024
Язык: Английский
Процитировано
1